EndoChoice today announced Scott Huennekens has been elevated to the position of Chairman of the Board.  Jim Balkcom, who has served as Chairman since 2009 will remain on the Board of Directors and continues to serve as Chairman of the Governance and Compliance Committee.

Under Balkcom's guidance as Chairman, EndoChoice grew from $3 millionin revenues in 2009 to more than $61 million in 2014.  "Jim Balkcom has been a wonderful partner for the executive team and a tremendous leader for our board," said Mark Gilreath, Founder and CEO of EndoChoice.  "Jim's commitment to 'servant leadership' has made a lasting impact on the culture of the company and I look forward to continuing our work together."

"It has been an honor to serve as Chairman during several years of extraordinary company growth," said Jim Balkcom.  "We are fortunate to have a leader such as Scott Huennekens to guide our board into the next chapter for EndoChoice." 

Mr. Huennekens has served as Chief Executive Officer of Volcano Corporation, a manufacturer of intravascular imaging equipment. From April 2002 to February 2015 he led Volcano from a startup to a public company with annual sales of approximately $400 million. Volcano was acquired in February 2015 by Royal Philips for $1.2 billion.  Previously, he served as President and Chief Executive Officer of Digirad Corporation and held senior positions at Baxter International. Mr. Huennekens currently serves as the Chairman of the Board for the Medical Device Manufacturers Association (MDMA).

"EndoChoice is one of the most exciting stories in the medical industry and I'm honored to accept the role of Chairman," said Scott Huennekens.  "It's a pleasure to work alongside Jim and Mark and I look forward to supporting the global EndoChoice team."